These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31903164)

  • 21. Tunneling Nanotubes Mediated microRNA-155 Intercellular Transportation Promotes Bladder Cancer Cells' Invasive and Proliferative Capacity.
    Lu JJ; Yang WM; Li F; Zhu W; Chen Z
    Int J Nanomedicine; 2019; 14():9731-9743. PubMed ID: 31849465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin.
    Zhu H; Yun F; Shi X; Wang D
    Int J Mol Med; 2015 Aug; 36(2):595-601. PubMed ID: 26080829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway.
    Chen YT; Yang CC; Shao PL; Huang CR; Yip HK
    J Pineal Res; 2019 Jan; 66(1):e12536. PubMed ID: 30372570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
    Wu CL; Ho JY; Chou SC; Yu DS
    Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the tumorigenic phenotype of human bladder cancer cells by combining with fetal rat mesenchyme.
    Miki M; Ishii K; Sasaki T; Kato M; Kajiwara S; Kanda H; Arima K; Hirokawa Y; Watanabe M; Sugimura Y
    Urol Oncol; 2018 Oct; 36(10):472.e1-472.e9. PubMed ID: 30139660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.
    Adam L; Zhong M; Choi W; Qi W; Nicoloso M; Arora A; Calin G; Wang H; Siefker-Radtke A; McConkey D; Bar-Eli M; Dinney C
    Clin Cancer Res; 2009 Aug; 15(16):5060-72. PubMed ID: 19671845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TIS111D can affect bladder cancer cells by regulating epithelial-mesenchymal transition.
    Lei Y; Yang L; Hongwei J; Hongyuan Y; Tao L
    Life Sci; 2019 Oct; 235():116832. PubMed ID: 31491455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transition.
    Chen DJ; Chen W; Jiang H; Yang H; Wang YC; Chen JH
    Drug Des Devel Ther; 2016; 10():2845-2853. PubMed ID: 27660415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells.
    Mansor R; Holly J; Barker R; Biernacka K; Zielinska H; Koupparis A; Rowe E; Oxley J; Sewell A; Martin RM; Lane A; Hackshaw-McGeagh L; Perks C
    Oncotarget; 2020 Jun; 11(26):2543-2559. PubMed ID: 32655839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin.
    Zhao L; Li QQ; Zhang R; Xi M; Liao YJ; Qian D; He LR; Zeng YX; Xie D; Liu MZ
    Tumour Biol; 2012 Aug; 33(4):1115-23. PubMed ID: 22389159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of Pokemon on bladder cancer epithelial-mesenchymal transition.
    Guo C; Zhu K; Sun W; Yang B; Gu W; Luo J; Peng B; Zheng J
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1226-31. PubMed ID: 24393848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation.
    Li X; Wang H; Wang J; Chen Y; Yin X; Shi G; Li H; Hu Z; Liang X
    BMC Cancer; 2016 Aug; 16():578. PubMed ID: 27485374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation status of insulin-like growth factor-binding protein 7 concurs with the malignance of oral tongue cancer.
    Chen LH; Liu DW; Chang JL; Chen PR; Hsu LP; Lin HY; Chou YF; Lee CF; Yang MC; Wen YH; Hsu WL; Weng CF
    J Exp Clin Cancer Res; 2015 Feb; 34(1):20. PubMed ID: 25880247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer.
    Nordentoft I; Dyrskjøt L; Bødker JS; Wild PJ; Hartmann A; Bertz S; Lehmann J; Orntoft TF; Birkenkamp-Demtroder K
    BMC Cancer; 2011 Apr; 11():135. PubMed ID: 21489314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro.
    Smolensky D; Rathore K; Cekanova M
    BMC Cancer; 2015 Nov; 15():927. PubMed ID: 26597249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-367-3p directly targets RAB23 and inhibits proliferation, migration and invasion of bladder cancer cells and increases cisplatin sensitivity.
    Wei X; Jiang Y; Yang G; Chang T; Sun G; Chen S; Wu S; Liu R
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17807-17821. PubMed ID: 37935937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successive treatment with naltrexone induces epithelial-mesenchymal transition and facilitates the malignant biological behaviors of bladder cancer cells.
    Wang X; Zhang R; Wu T; Shi Y; Zhou X; Tang D; Yu W; So EC; Wu X; Pan Z; Tian J
    Acta Biochim Biophys Sin (Shanghai); 2021 Feb; 53(2):238-248. PubMed ID: 33410473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of GATA3 in bladder cancer promotes cell migration and invasion.
    Li Y; Ishiguro H; Kawahara T; Kashiwagi E; Izumi K; Miyamoto H
    Cancer Biol Ther; 2014 Apr; 15(4):428-35. PubMed ID: 24448324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.